Vasopressor resident survival guide

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Overview

Management

Norepinephrine Dopamine Vasopressin Phenylephrine Dobutamine
Mechanism Mainly predominantα1 agonist (Vasoconstrictive)
*some β1 agonist (↑contractility)
*Mainly predominant β1 agonist (↑ cardiac contractility)
* some α1 agonist(Vasoconstrictive)
*V1 receptor of GIT vasculatures
*Antidiuretic effects
*Pure α1 agonist(Vasoconstrictive)
*No β1
*Predominant β1 agonist (↑contractility)
*β2 arterial smooth muscle (Hypotensive)
Indication *1st line in :
*Septic shock
*Cardiogenic shock
*Undifferentiated shock
2nd line septic shock 2nd line septic shock 1st line Neurogenic shock
3rd-4th line septic shock
*1st line cardiogenic shock
* low output septic shock
Dose 1-30 mcg/min
0.01-0.3mcg/kg/min
2-20 mcg/min 0.03 unit/min 20-300 mcg/kg/min 2.5-20 mcg/kg/min
Complications Tachyarrhythmia {less β1 effect}
( less than Dopamine )
Arrhythmia (more β1) *Coronary spasm
*Splanchnic vasoconstriction
Reflex bradycardia
(only α1)
Hypotension (β2)
Cautions Arrhythmia *Not in cardiogenic shock
*Arrhythmia
*Ischemia induced cardiotoxicity
*Ischemic heart
*Gut ischemia
*Bradycardia
*Heart block
*Hypotension (add α1 agonist)

Do's

  • Assess the cause of shock
  • Always volume fluid resuscitation first
  • Norepinephrine in undifferentiated shock.
  • Titrate dobutamine according to clinical response slowly ( 2-20 ug/kg/min ) to avoid tachycardia (10% increase from the baseline). The benefit that dobutamine has as minimal effect on myocardial oxygen demand is lost if it is not well titrated.

Don'ts

  • Do not start with low dose Dopamine dose to perfuse the kidney.

References

Template:WH Template:WS